The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Montelukast Drug-Global Market Insights and Sales Trends 2025

Montelukast Drug-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1808744

No of Pages : 120

Ask Your Query
Synopsis
Montelukast is a leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies.
The global Montelukast Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Montelukast Drug in various end use industries. The expanding demands from the Hospital, Drug Store and Others,, are propelling Montelukast Drug market. Tablets, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Oral Granules segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Montelukast Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Montelukast Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Montelukast Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Montelukast Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Montelukast Drug covered in this report include Merck & Co., Teva, Mylan, Glenmark Pharmaceuticals, Hikma Group, Sandoz, Torrent Pharmaceuticals, Lannett Company and Apotex, etc.
The global Montelukast Drug market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck & Co.
Teva
Mylan
Glenmark Pharmaceuticals
Hikma Group
Sandoz
Torrent Pharmaceuticals
Lannett Company
Apotex
Dr. Reddys Laboratories
Aurobindo Pharma
Accord Healthcare
Hetero
Unimark
Ajanta Pharma
MACLEODS
Jubilant Pharma
Unichem Laboratories
Amneal Pharmaceuticals
Shanghai Anbison Lab
Perrigo
Cipla
CSPC Ouyi Pharmaceutical
Global Montelukast Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Montelukast Drug market, Segment by Type:
Tablets
Oral Granules
Global Montelukast Drug market, by Application
Hospital
Drug Store
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Montelukast Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Montelukast Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Montelukast Drug Market Overview
1.1 Montelukast Drug Product Overview
1.2 Montelukast Drug Market Segment by Type
1.2.1 Tablets
1.2.2 Oral Granules
1.3 Global Montelukast Drug Market Size by Type
1.3.1 Global Montelukast Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Montelukast Drug Historic Market Size Review by Type (2018-2023)
1.3.3 Global Montelukast Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Montelukast Drug Sales Breakdown by Type (2018-2023)
1.4.2 Europe Montelukast Drug Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Montelukast Drug Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Montelukast Drug Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Montelukast Drug Sales Breakdown by Type (2018-2023)
2 Global Montelukast Drug Market Competition by Company
2.1 Global Top Players by Montelukast Drug Sales (2018-2023)
2.2 Global Top Players by Montelukast Drug Revenue (2018-2023)
2.3 Global Top Players by Montelukast Drug Price (2018-2023)
2.4 Global Top Manufacturers Montelukast Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Montelukast Drug Market Competitive Situation and Trends
2.5.1 Montelukast Drug Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Montelukast Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Montelukast Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Montelukast Drug Market
2.8 Key Manufacturers Montelukast Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Montelukast Drug Status and Outlook by Region
3.1 Global Montelukast Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Montelukast Drug Historic Market Size by Region
3.2.1 Global Montelukast Drug Sales in Volume by Region (2018-2023)
3.2.2 Global Montelukast Drug Sales in Value by Region (2018-2023)
3.2.3 Global Montelukast Drug Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Montelukast Drug Forecasted Market Size by Region
3.3.1 Global Montelukast Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Montelukast Drug Sales in Value by Region (2024-2029)
3.3.3 Global Montelukast Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Montelukast Drug by Application
4.1 Montelukast Drug Market Segment by Application
4.1.1 Hospital
4.1.2 Drug Store
4.1.3 Others
4.2 Global Montelukast Drug Market Size by Application
4.2.1 Global Montelukast Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Montelukast Drug Historic Market Size Review by Application (2018-2023)
4.2.3 Global Montelukast Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Montelukast Drug Sales Breakdown by Application (2018-2023)
4.3.2 Europe Montelukast Drug Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Montelukast Drug Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Montelukast Drug Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Montelukast Drug Sales Breakdown by Application (2018-2023)
5 North America Montelukast Drug by Country
5.1 North America Montelukast Drug Historic Market Size by Country
5.1.1 North America Montelukast Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Montelukast Drug Sales in Volume by Country (2018-2023)
5.1.3 North America Montelukast Drug Sales in Value by Country (2018-2023)
5.2 North America Montelukast Drug Forecasted Market Size by Country
5.2.1 North America Montelukast Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Montelukast Drug Sales in Value by Country (2024-2029)
6 Europe Montelukast Drug by Country
6.1 Europe Montelukast Drug Historic Market Size by Country
6.1.1 Europe Montelukast Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Montelukast Drug Sales in Volume by Country (2018-2023)
6.1.3 Europe Montelukast Drug Sales in Value by Country (2018-2023)
6.2 Europe Montelukast Drug Forecasted Market Size by Country
6.2.1 Europe Montelukast Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Montelukast Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Montelukast Drug by Region
7.1 Asia-Pacific Montelukast Drug Historic Market Size by Region
7.1.1 Asia-Pacific Montelukast Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Montelukast Drug Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Montelukast Drug Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Montelukast Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Montelukast Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Montelukast Drug Sales in Value by Region (2024-2029)
8 Latin America Montelukast Drug by Country
8.1 Latin America Montelukast Drug Historic Market Size by Country
8.1.1 Latin America Montelukast Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Montelukast Drug Sales in Volume by Country (2018-2023)
8.1.3 Latin America Montelukast Drug Sales in Value by Country (2018-2023)
8.2 Latin America Montelukast Drug Forecasted Market Size by Country
8.2.1 Latin America Montelukast Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Montelukast Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Montelukast Drug by Country
9.1 Middle East and Africa Montelukast Drug Historic Market Size by Country
9.1.1 Middle East and Africa Montelukast Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Montelukast Drug Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Montelukast Drug Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Montelukast Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Montelukast Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Montelukast Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck & Co.
10.1.1 Merck & Co. Company Information
10.1.2 Merck & Co. Introduction and Business Overview
10.1.3 Merck & Co. Montelukast Drug Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merck & Co. Montelukast Drug Products Offered
10.1.5 Merck & Co. Recent Development
10.2 Teva
10.2.1 Teva Company Information
10.2.2 Teva Introduction and Business Overview
10.2.3 Teva Montelukast Drug Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Teva Montelukast Drug Products Offered
10.2.5 Teva Recent Development
10.3 Mylan
10.3.1 Mylan Company Information
10.3.2 Mylan Introduction and Business Overview
10.3.3 Mylan Montelukast Drug Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Mylan Montelukast Drug Products Offered
10.3.5 Mylan Recent Development
10.4 Glenmark Pharmaceuticals
10.4.1 Glenmark Pharmaceuticals Company Information
10.4.2 Glenmark Pharmaceuticals Introduction and Business Overview
10.4.3 Glenmark Pharmaceuticals Montelukast Drug Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Glenmark Pharmaceuticals Montelukast Drug Products Offered
10.4.5 Glenmark Pharmaceuticals Recent Development
10.5 Hikma Group
10.5.1 Hikma Group Company Information
10.5.2 Hikma Group Introduction and Business Overview
10.5.3 Hikma Group Montelukast Drug Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Hikma Group Montelukast Drug Products Offered
10.5.5 Hikma Group Recent Development
10.6 Sandoz
10.6.1 Sandoz Company Information
10.6.2 Sandoz Introduction and Business Overview
10.6.3 Sandoz Montelukast Drug Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Sandoz Montelukast Drug Products Offered
10.6.5 Sandoz Recent Development
10.7 Torrent Pharmaceuticals
10.7.1 Torrent Pharmaceuticals Company Information
10.7.2 Torrent Pharmaceuticals Introduction and Business Overview
10.7.3 Torrent Pharmaceuticals Montelukast Drug Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Torrent Pharmaceuticals Montelukast Drug Products Offered
10.7.5 Torrent Pharmaceuticals Recent Development
10.8 Lannett Company
10.8.1 Lannett Company Company Information
10.8.2 Lannett Company Introduction and Business Overview
10.8.3 Lannett Company Montelukast Drug Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Lannett Company Montelukast Drug Products Offered
10.8.5 Lannett Company Recent Development
10.9 Apotex
10.9.1 Apotex Company Information
10.9.2 Apotex Introduction and Business Overview
10.9.3 Apotex Montelukast Drug Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Apotex Montelukast Drug Products Offered
10.9.5 Apotex Recent Development
10.10 Dr. Reddys Laboratories
10.10.1 Dr. Reddys Laboratories Company Information
10.10.2 Dr. Reddys Laboratories Introduction and Business Overview
10.10.3 Dr. Reddys Laboratories Montelukast Drug Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Dr. Reddys Laboratories Montelukast Drug Products Offered
10.10.5 Dr. Reddys Laboratories Recent Development
10.11 Aurobindo Pharma
10.11.1 Aurobindo Pharma Company Information
10.11.2 Aurobindo Pharma Introduction and Business Overview
10.11.3 Aurobindo Pharma Montelukast Drug Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Aurobindo Pharma Montelukast Drug Products Offered
10.11.5 Aurobindo Pharma Recent Development
10.12 Accord Healthcare
10.12.1 Accord Healthcare Company Information
10.12.2 Accord Healthcare Introduction and Business Overview
10.12.3 Accord Healthcare Montelukast Drug Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Accord Healthcare Montelukast Drug Products Offered
10.12.5 Accord Healthcare Recent Development
10.13 Hetero
10.13.1 Hetero Company Information
10.13.2 Hetero Introduction and Business Overview
10.13.3 Hetero Montelukast Drug Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Hetero Montelukast Drug Products Offered
10.13.5 Hetero Recent Development
10.14 Unimark
10.14.1 Unimark Company Information
10.14.2 Unimark Introduction and Business Overview
10.14.3 Unimark Montelukast Drug Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Unimark Montelukast Drug Products Offered
10.14.5 Unimark Recent Development
10.15 Ajanta Pharma
10.15.1 Ajanta Pharma Company Information
10.15.2 Ajanta Pharma Introduction and Business Overview
10.15.3 Ajanta Pharma Montelukast Drug Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Ajanta Pharma Montelukast Drug Products Offered
10.15.5 Ajanta Pharma Recent Development
10.16 MACLEODS
10.16.1 MACLEODS Company Information
10.16.2 MACLEODS Introduction and Business Overview
10.16.3 MACLEODS Montelukast Drug Sales, Revenue and Gross Margin (2018-2023)
10.16.4 MACLEODS Montelukast Drug Products Offered
10.16.5 MACLEODS Recent Development
10.17 Jubilant Pharma
10.17.1 Jubilant Pharma Company Information
10.17.2 Jubilant Pharma Introduction and Business Overview
10.17.3 Jubilant Pharma Montelukast Drug Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Jubilant Pharma Montelukast Drug Products Offered
10.17.5 Jubilant Pharma Recent Development
10.18 Unichem Laboratories
10.18.1 Unichem Laboratories Company Information
10.18.2 Unichem Laboratories Introduction and Business Overview
10.18.3 Unichem Laboratories Montelukast Drug Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Unichem Laboratories Montelukast Drug Products Offered
10.18.5 Unichem Laboratories Recent Development
10.19 Amneal Pharmaceuticals
10.19.1 Amneal Pharmaceuticals Company Information
10.19.2 Amneal Pharmaceuticals Introduction and Business Overview
10.19.3 Amneal Pharmaceuticals Montelukast Drug Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Amneal Pharmaceuticals Montelukast Drug Products Offered
10.19.5 Amneal Pharmaceuticals Recent Development
10.20 Shanghai Anbison Lab
10.20.1 Shanghai Anbison Lab Company Information
10.20.2 Shanghai Anbison Lab Introduction and Business Overview
10.20.3 Shanghai Anbison Lab Montelukast Drug Sales, Revenue and Gross Margin (2018-2023)
10.20.4 Shanghai Anbison Lab Montelukast Drug Products Offered
10.20.5 Shanghai Anbison Lab Recent Development
10.21 Perrigo
10.21.1 Perrigo Company Information
10.21.2 Perrigo Introduction and Business Overview
10.21.3 Perrigo Montelukast Drug Sales, Revenue and Gross Margin (2018-2023)
10.21.4 Perrigo Montelukast Drug Products Offered
10.21.5 Perrigo Recent Development
10.22 Cipla
10.22.1 Cipla Company Information
10.22.2 Cipla Introduction and Business Overview
10.22.3 Cipla Montelukast Drug Sales, Revenue and Gross Margin (2018-2023)
10.22.4 Cipla Montelukast Drug Products Offered
10.22.5 Cipla Recent Development
10.23 CSPC Ouyi Pharmaceutical
10.23.1 CSPC Ouyi Pharmaceutical Company Information
10.23.2 CSPC Ouyi Pharmaceutical Introduction and Business Overview
10.23.3 CSPC Ouyi Pharmaceutical Montelukast Drug Sales, Revenue and Gross Margin (2018-2023)
10.23.4 CSPC Ouyi Pharmaceutical Montelukast Drug Products Offered
10.23.5 CSPC Ouyi Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Montelukast Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Montelukast Drug Industrial Chain Analysis
11.4 Montelukast Drug Market Dynamics
11.4.1 Montelukast Drug Industry Trends
11.4.2 Montelukast Drug Market Drivers
11.4.3 Montelukast Drug Market Challenges
11.4.4 Montelukast Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Montelukast Drug Distributors
12.3 Montelukast Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock